|
[1]
|
Kupka MS, D'Hooghe T, Ferraretti AP, et al. Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE[J]. Hum Reprod, 2016, 31:233-248. https://www.researchgate.net/publication/289535487_Assisted_reproductive_technology_in_Europe_2011_Results_generated_from_European_registers_by_ESHRE |
|
[2]
|
Stephen EH, Chandra A, King RB. Supply of and demand for assisted reproductive technologies in the United States: clinic- and population-based data, 1995-2010[J]. Fertil Steril, 2016, 105:451-458. doi: 10.1016/j.fertnstert.2015.10.007 |
|
[3]
|
Chang J, Boulet SL, Jeng G, et al. Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011-2012[J]. Fertil Steril, 2016, 105:394-400. doi: 10.1016/j.fertnstert.2015.10.018 |
|
[4]
|
Smith AD, Tilling K, Nelson SM, et al. Live-birth rate associated with repeat in vitro fertilization treatment cycles[J]. JAMA, 2015, 314:2654-2662. doi: 10.1001/jama.2015.17296 |
|
[5]
|
Takeshima K, Jwa SC, Saito H, et al. Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles-analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012[J]. Fertil Steril, 2016, 105:337-346.e3. doi: 10.1016/j.fertnstert.2015.10.002 |
|
[6]
|
Crawford S, Boulet SL, Mneimneh AS, et al. Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches[J]. Fertil Steril, 2016, 105:444-450. doi: 10.1016/j.fertnstert.2015.10.032 |
|
[7]
|
Qin J, Liu X, Sheng X, et al. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies[J]. Fertil Steril, 2016, 105:73-85.e6. doi: 10.1016/j.fertnstert.2015.09.007 |
|
[8]
|
Martin AS, Monsour M, Kissin DM, et al. Trends in severe maternal morbidity after assisted reproductive technology in the United States, 2008-2012[J]. Obstet Gynecol, 2016, 127:59-66. doi: 10.1097/AOG.0000000000001197 |
|
[9]
|
Dickey RP, Xiong X, Pridjian G, et al. Singleton birthweight by gestational age following in vitro fertilization in the United States[J]. Am J Obstet Gynecol, 2016, 214:101.e1-101.e13. doi: 10.1016/j.ajog.2015.08.008 |
|
[10]
|
Bonne S, Sauleau E, Sananes N, et al. Influence of medically assisted reproduction techniques on crown-rump length and biochemical markers of trisomy 21 in the first trimester of pregnancy[J]. Fertil Steril, 2016, 105:410-416. doi: 10.1016/j.fertnstert.2015.10.031 |
|
[11]
|
Cardozo ER, Karmon AE, Gold J, et al. Reproductive outcomes in oocyte donation cycles are associated with donor BMI[J]. Hum Reprod, 2016, 31:385-392. http://www.researchgate.net/publication/307618915_Reproductive_outcomes_in_recipients_are_not_associated_with_oocyte_donor_body_mass_index_BMI_a_cohort_study_of_2927_cycles |
|
[12]
|
Provost MP, Acharya KS, Acharya CR, et al. Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22, 317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry[J]. Fertil Steril, 2016, 105:364-368. doi: 10.1016/j.fertnstert.2015.10.015 |
|
[13]
|
Doyle JO, Richter KS, Lim J, et al. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval[J]. Fertil Steril, 2016, 105:459-466.e2. doi: 10.1016/j.fertnstert.2015.10.026 |
|
[14]
|
Luke B, Brown MB, Missmer SA, et al. Assisted reprouctive technology use and outcomes among women with a history of cancer[J]. Hum Reprod, 2016, 31:183-189. doi: 10.1093/humrep/dev288 |
|
[15]
|
Bouet PE, El Hachem H, Monceau E, et al. Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis[J]. Fertil Steril, 2016, 105:106-110. doi: 10.1016/j.fertnstert.2015.09.025 |
|
[16]
|
Zhang JJ, Merhi Z, Yang M, et al. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial[J]. Am J Obstet Gynecol, 2016, 214:96.e1-96.e8. doi: 10.1016/j.ajog.2015.08.009 |
|
[17]
|
Vuong TN, Ho MT, Ha TD, et al. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study[J].Fertil Steril, 2016, 105:356-363. doi: 10.1016/j.fertnstert.2015.10.014 |
|
[18]
|
Healy MW, Patounakis G, Connell MT, et al. Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles? [J].Fertil Steril, 2016, 105:93-99.e1. doi: 10.1016/j.fertnstert.2015.09.015 |
|
[19]
|
Martinez F, Rodriguez I, Devesa M, et al. Should progesterone on the human chorionic gonadotropin day still be measured? [J].Fertil Steril, 2016, 105:86-92. doi: 10.1016/j.fertnstert.2015.09.008 |
|
[20]
|
Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained subfertility[J]. Cochrane Database Syst Rev, 2015, 11:CD003357. doi: 10.1002/14651858.CD003357.pub2/references |
|
[21]
|
Nagels HE, Rishworth JR, Siristatidis CS, et al. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction[J]. Cochrane Database Syst Rev, 2015, 11:CD009749. http://www.ncbi.nlm.nih.gov/pubmed/26608695 |
|
[22]
|
Pereira N, Amrane S, Estes JL, et al. Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes? [J].Fertil Steril, 2016, 105:539-544.e1. doi: 10.1016/j.fertnstert.2015.10.028 |
|
[23]
|
Garolla A, Engl B, Pizzol D, et al. Spontaneous fertility and in vitro fertilization outcome: new evidence of human papillomavirus sperm infection[J]. Fertil Steril, 2016, 105:65-72.e1. doi: 10.1016/j.fertnstert.2015.09.018 |
|
[24]
|
Gharagozloo P, Gutierrez-Adan A, Champroux A, et al. A novel antioxidant formulation designed to treat male infertility associated with oxidative stress: promising preclinical evidence from animal models[J]. Hum Reprod, 2016, 31:252-262. doi: 10.1093/humrep/dev302 |
|
[25]
|
Kurabayashi T, Mizunuma H, Kubota T, et al. Ovarian infertility is associated with cardiovascular disease risk factors in later life: A Japanese cross-sectional study[J]. Maturitas, 2016, 83:33-39. doi: 10.1016/j.maturitas.2015.08.015 |
|
[26]
|
Messerlian C, Souter I, Gaskins AJ, et al. Urinary phthalate metabolites and ovarian reserve among women seeking infertility care[J]. Hum Reprod, 2016, 31:75-83. doi: 10.1093/humrep/dev292 |
|
[27]
|
Grynberg M, Bidet M, Benard J, et al. Fertility preservation in Turner syndrome[J]. Fertil Steril, 2016, 105:13-19. doi: 10.1016/j.fertnstert.2015.11.042 |
|
[28]
|
Oktay K, Bedoschi G, Pacheco F, et al. First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellularrix scaffold using robot-assisted minimally invasive surgery[J]. Am J Obstet Gynecol, 2016, 214:94.e1-94.e9. doi: 10.1016/j.ajog.2015.10.001 |
|
[29]
|
Yu L, Peterson B, Inhorn MC, et al. Knowledge, attitudes, and intentions toward fertility awareness and oocyte cryopreservation among obstetrics and gynecology resident physicians[J]. Hum Reprod, 2016, 31:403-411. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=e3a9e979237c0bd689e765392cf9cbbf |
作者投稿
专家审稿
编辑办公
邮件订阅
RSS
点击查看大图
下载:
